Lankem Ceylon Plc

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: LK0115N00002
LKR
45.10
-1.8 (-3.84%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Debt company with Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of 20.14% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Capital Employed (avg) of 14.52% signifying low profitability per unit of total capital (equity and debt)
2

The company has declared Negative results for the last 3 consecutive quarters

3

Risky -

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

LKR Million (Small Cap)

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

3.19

stock-summary
Return on Equity

-9.91%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
10,501 Million
(Quarterly Results - Dec 2025)
Net Profit:
157 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.11%
0%
0.11%
6 Months
19.17%
0%
19.17%
1 Year
17.07%
0%
17.07%
2 Years
77.27%
0%
77.27%
3 Years
12.34%
0%
12.34%
4 Years
185.66%
0%
185.66%
5 Years
304.42%
0%
304.42%

Lankem Ceylon Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
20.14%
EBIT Growth (5y)
24.52%
EBIT to Interest (avg)
1.19
Debt to EBITDA (avg)
6.20
Net Debt to Equity (avg)
4.43
Sales to Capital Employed (avg)
2.10
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.52%
ROE (avg)
15.01%

Valuation key factors

Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
9.47
EV to EBITDA
7.30
EV to Capital Employed
0.82
EV to Sales
0.38
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
8.63%
ROE (Latest)
-13.45%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 10.69% vs 1.88% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 206.31% vs 33.74% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,500.70",
          "val2": "9,487.00",
          "chgp": "10.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "599.30",
          "val2": "235.80",
          "chgp": "154.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "199.50",
          "val2": "343.00",
          "chgp": "-41.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "156.80",
          "val2": "-147.50",
          "chgp": "206.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.30%",
          "val2": "7.90%",
          "chgp": "3.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 20.04% vs -0.45% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 62.24% vs -136.91% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "40,334.10",
          "val2": "33,601.70",
          "chgp": "20.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,333.50",
          "val2": "2,208.90",
          "chgp": "5.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,791.60",
          "val2": "2,126.20",
          "chgp": "-15.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "33.60",
          "val2": "4.00",
          "chgp": "740.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-325.50",
          "val2": "-862.10",
          "chgp": "62.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "44.30%",
          "val2": "50.80%",
          "chgp": "-0.65%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
10,500.70
9,487.00
10.69%
Operating Profit (PBDIT) excl Other Income
599.30
235.80
154.16%
Interest
199.50
343.00
-41.84%
Exceptional Items
0.00
0.00
Consolidate Net Profit
156.80
-147.50
206.31%
Operating Profit Margin (Excl OI)
40.30%
7.90%
3.24%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 10.69% vs 1.88% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 206.31% vs 33.74% in Sep 2025

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
40,334.10
33,601.70
20.04%
Operating Profit (PBDIT) excl Other Income
2,333.50
2,208.90
5.64%
Interest
1,791.60
2,126.20
-15.74%
Exceptional Items
33.60
4.00
740.00%
Consolidate Net Profit
-325.50
-862.10
62.24%
Operating Profit Margin (Excl OI)
44.30%
50.80%
-0.65%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 20.04% vs -0.45% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 62.24% vs -136.91% in Mar 2024

stock-summaryCompany CV
About Lankem Ceylon Plc stock-summary
stock-summary
Lankem Ceylon Plc
Specialty Chemicals
Lankem Ceylon PLC is engaged in manufacturing of chemicals, paints and consumer products. The Company's segments include Trading Consumer Products, Trading Industrial Products, Leisure and Others. The Trading Consumer Products segment is engaged in manufacturing, selling and distribution of consumer products. The Trading Industrial Products segment is engaged in manufacturing, selling and distribution of industrial products. The Leisure segment is engaged in owning and operation of resort hotels. The Others segment includes special projects and other services. The Company's business areas are agri-inputs, bituminous products, packaging, leisure, pest control and construction. It serves various industries, such as food and feed ingredients, industrial flooring, plantations and road surfacing. The Company's subsidiaries include Lankem Paints Ltd., Lankem Consumer Products Ltd., SunAgro Life Science Ltd., SunAgro Foods Ltd. and Lankem Technology Services Ltd., among others.
Company Coordinates stock-summary
Company Details
98, Sri Sangaraja Mawatha, Colombo 10 , COLOMBO None : 10
stock-summary
Tel: 94 11 2478790
stock-summary
Registrar Details